Markets

Medicago Awarded Contract From U.S. Department of Defence for Potential Future Production; Shrs Rose 5% Friday

Medicago Inc. (MDG.TO), which rose 5% and further away from near year lows Friday, announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract from the Defense Advanced Research Projects Agency (DARPA) based on Medicago having met all the technical requirement standards for the contract. As a result of Medicago having met these requirements and standards, Medicago is now allowed to bid for the manufacture and delivery of certain tobacco-produced proteins, for which Medicago has already demonstrated a proven ability. Medicago intends to bid on these orders when solicitations are next issued by the U.S. government and may be awarded production contracts.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Commodities

Latest Markets Videos